A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United States

被引:11
作者
Nauck, M
Graziani, MS
Jarausch, J
Bruton, D
Cobbaert, C
Cole, TG
Colella, F
Lefevre, F
Gillery, P
Haas, B
Law, T
König, M
Macke, M
März, W
Meier, C
Riesen, W
van Vliet, M
Wieland, H
Rifai, N
机构
[1] Univ Hosp Freiburg, Dept Clin Chem, D-79106 Freiburg, Germany
[2] Lab Chim Clin, Verona, Italy
[3] Roche Diagnost, Evaluat Dept, Mannheim, Germany
[4] Acad Hosp Rotterdam Dijkzigt, Dept Clin Chem, Lipid Reference Lab, Rotterdam, Netherlands
[5] Washington Univ, Sch Med, Core Lab Clin Studies, St Louis, MO USA
[6] Hop Robert Debre, Lab Cent Biochem, Reims, France
[7] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA
[8] Inst Klin Chem & Hamatol Kantons, St Gallen, Switzerland
[9] Roche Diagnost, Evaluat Dept, Indianapolis, IN USA
关键词
low density lipoprotein (LDL); high density lipoprotein (HDL); lipoprotein cholesterol;
D O I
10.1515/CCLM.1999.156
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We evaluated a new liquid homogeneous assay for the direct measurement of high density lipoprotein cholesterol (HDL-C Plus) in seven laboratories. The assay includes two reagents which can be readily used in most available clinical chemistry analyzers. The total CVs of the new method were below 4.6% and the bias in relation to the designated comparison method was below 3.9%. The total error ranged between 4 to 7%. HDL-C values determined by this method were in good agreement with those obtained by the old homogeneous assay using lyophilized reagents, and other homogeneous and precipitation assays (0.944 < r < 0.996). The assay was linear up to at least 3.89 mmol/l HDL-C. Hemoglobin did not interfere, whereas in icteric samples slight deviations were observed. Lipemia up to 11.3 to 22.6 mmol/l triglycerides did not interfere with this homogeneous HDL-C assay. In samples of patients with paraproteinemia, discrepant results were seen. This liquid homogeneous HDL-C assay was easy to handle and produced similar results in all laboratories participating in this study. This method will enable clinical laboratories to reliably measure HDL-C for risk assessment of coronary heart disease.
引用
收藏
页码:1067 / 1076
页数:10
相关论文
共 41 条
[1]   DISTRIBUTION OF HDL2 AND HDL3 IN A RANDOM-POPULATION OF HEALTHY FRENCH MALES AND FEMALES - EVALUATION BY A 2-STEP PRECIPITATION PROCEDURE [J].
ATGER, V ;
WIRBEL, E ;
ROCHE, D ;
APFELBAUM, M ;
BURSTEIN, M ;
GIRARDGLOBA, A .
CLINICA CHIMICA ACTA, 1990, 189 (02) :111-122
[2]   MEASUREMENT OF PLASMA-CONCENTRATIONS OF POLYMORPHONUCLEAR ELASTASE-ALPHA-1 PROTEINASE-INHIBITOR (ELASTASE-ALPHA-1 ANTITRYPSIN) IN PATIENTS WITH RHEUMATOID-ARTHRITIS - INTERFERENCE BY RHEUMATOID-FACTOR [J].
BANKS, RE ;
EVANS, SW ;
TAYLOR, KF ;
BIRD, HA ;
WHICHER, JT .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (01) :18-21
[3]  
BEHESHTI I, 1994, CLIN CHEM, V40, P2088
[4]  
CAREY RN, 1996, CLIN CHEM THEORY ANA, P402
[5]   OVERESTIMATION OF IMMUNOGLOBULINS IN THE PRESENCE OF RHEUMATOID-FACTOR BY KINETIC IMMUNONEPHELOMETRY AND RAPID IMMUNOTURBIDIMETRY [J].
CHAMBERS, RE ;
WHICHER, JT ;
PERRY, DE ;
MILFORDWARD, A ;
WHITE, PAE ;
FIFIELD, R .
ANNALS OF CLINICAL BIOCHEMISTRY, 1987, 24 :520-524
[6]   HIGH-DENSITY-LIPOPROTEIN SUBPOPULATIONS IN CHRONIC LIVER-DISEASE [J].
CHANG, L ;
CLIFTON, P ;
BARTER, P ;
MACKINNON, M .
HEPATOLOGY, 1986, 6 (01) :46-49
[7]  
CLOEY T, 1992, JAMA-J AM MED ASSOC, V267, P234
[8]  
Cobbaert C, 1998, CLIN CHEM, V44, P779
[9]   Evaluation of five different high-density lipoprotein cholesterol assays: the most precise are not the most accurate [J].
de Keijzer, MH ;
Elbers, D ;
Baadenhuijsen, H ;
Demacker, PNM .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :168-175
[10]  
Demacker PNM, 1997, CLIN CHEM, V43, P663